HOWL Insider Transactions — Page 4
587 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 301–400; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| GADICKE ANSBERT | TenPercentOwner | 2025-11-17 | Sale | 57,061.0 | $0.95 |
| MPM ASSET MANAGEMENT LLC | TenPercentOwner | 2025-11-17 | Sale | 57,061.0 | $0.95 |
| MPM BioImpact LLC | TenPercentOwner | 2025-11-17 | Sale | 57,061.0 | $0.95 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2025-11-17 | Sale | 57,061.0 | $0.95 |
| MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | 2025-11-17 | Sale | 57,061.0 | $0.95 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2025-11-17 | Sale | 57,061.0 | $0.95 |
| MPM Oncology Innovations Fund GP LLC | TenPercentOwner | 2025-11-17 | Sale | 57,061.0 | $0.95 |
| EVNIN LUKE | Director | 2025-11-17 | Sale | 36,621.0 | $0.95 |
| MPM BioVentures 2014, L.P. | TenPercentOwner | 2025-11-14 | Sale | 61,640.0 | $0.93 |
| MPM BioVentures 2014 (B), L.P. | TenPercentOwner | 2025-11-14 | Sale | 61,640.0 | $0.93 |
| MPM Asset Management Investors BV2014 LLC | TenPercentOwner | 2025-11-14 | Sale | 61,640.0 | $0.93 |
| MPM BioVentures 2014 LLC | TenPercentOwner | 2025-11-14 | Sale | 61,640.0 | $0.93 |
| MPM BioVentures 2014 GP LLC | TenPercentOwner | 2025-11-14 | Sale | 61,640.0 | $0.93 |
| GADICKE ANSBERT | TenPercentOwner | 2025-11-14 | Sale | 61,640.0 | $0.93 |
| MPM ASSET MANAGEMENT LLC | TenPercentOwner | 2025-11-14 | Sale | 61,640.0 | $0.93 |
| MPM BioImpact LLC | TenPercentOwner | 2025-11-14 | Sale | 61,640.0 | $0.93 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2025-11-14 | Sale | 61,640.0 | $0.93 |
| MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | 2025-11-14 | Sale | 61,640.0 | $0.93 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2025-11-14 | Sale | 61,640.0 | $0.93 |
| MPM Oncology Innovations Fund GP LLC | TenPercentOwner | 2025-11-14 | Sale | 61,640.0 | $0.93 |
| EVNIN LUKE | Director | 2025-11-14 | Sale | 39,560.0 | $0.93 |
| MPM BioVentures 2014, L.P. | TenPercentOwner | 2025-11-13 | Sale | 90,951.0 | $0.98 |
| MPM BioVentures 2014 (B), L.P. | TenPercentOwner | 2025-11-13 | Sale | 90,951.0 | $0.98 |
| MPM Asset Management Investors BV2014 LLC | TenPercentOwner | 2025-11-13 | Sale | 90,951.0 | $0.98 |
| MPM BioVentures 2014 LLC | TenPercentOwner | 2025-11-13 | Sale | 90,951.0 | $0.98 |
| MPM BioVentures 2014 GP LLC | TenPercentOwner | 2025-11-13 | Sale | 90,951.0 | $0.98 |
| GADICKE ANSBERT | TenPercentOwner | 2025-11-13 | Sale | 90,951.0 | $0.98 |
| MPM ASSET MANAGEMENT LLC | TenPercentOwner | 2025-11-13 | Sale | 90,951.0 | $0.98 |
| MPM BioImpact LLC | TenPercentOwner | 2025-11-13 | Sale | 90,951.0 | $0.98 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2025-11-13 | Sale | 90,951.0 | $0.98 |
| MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | 2025-11-13 | Sale | 90,951.0 | $0.98 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2025-11-13 | Sale | 90,951.0 | $0.98 |
| MPM Oncology Innovations Fund GP LLC | TenPercentOwner | 2025-11-13 | Sale | 90,951.0 | $0.98 |
| EVNIN LUKE | Director | 2025-11-13 | Sale | 58,372.0 | $0.98 |
| MPM BioVentures 2014, L.P. | TenPercentOwner | 2025-11-12 | Sale | 40,669.0 | $1.09 |
| MPM BioVentures 2014 (B), L.P. | TenPercentOwner | 2025-11-12 | Sale | 40,669.0 | $1.09 |
| MPM Asset Management Investors BV2014 LLC | TenPercentOwner | 2025-11-12 | Sale | 40,669.0 | $1.09 |
| MPM BioVentures 2014 LLC | TenPercentOwner | 2025-11-12 | Sale | 40,669.0 | $1.09 |
| MPM BioVentures 2014 GP LLC | TenPercentOwner | 2025-11-12 | Sale | 40,669.0 | $1.09 |
| GADICKE ANSBERT | TenPercentOwner | 2025-11-12 | Sale | 40,669.0 | $1.09 |
| MPM ASSET MANAGEMENT LLC | TenPercentOwner | 2025-11-12 | Sale | 40,669.0 | $1.09 |
| MPM BioImpact LLC | TenPercentOwner | 2025-11-12 | Sale | 40,669.0 | $1.09 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2025-11-12 | Sale | 40,669.0 | $1.09 |
| MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | 2025-11-12 | Sale | 40,669.0 | $1.09 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2025-11-12 | Sale | 40,669.0 | $1.09 |
| MPM Oncology Innovations Fund GP LLC | TenPercentOwner | 2025-11-12 | Sale | 40,669.0 | $1.09 |
| EVNIN LUKE | Director | 2025-11-12 | Sale | 26,101.0 | $1.09 |
| MPM BioVentures 2014, L.P. | TenPercentOwner | 2025-11-11 | Sale | 55,810.0 | $1.14 |
| MPM BioVentures 2014 (B), L.P. | TenPercentOwner | 2025-11-11 | Sale | 55,810.0 | $1.14 |
| MPM Asset Management Investors BV2014 LLC | TenPercentOwner | 2025-11-11 | Sale | 55,810.0 | $1.14 |
| MPM BioVentures 2014 LLC | TenPercentOwner | 2025-11-11 | Sale | 55,810.0 | $1.14 |
| MPM BioVentures 2014 GP LLC | TenPercentOwner | 2025-11-11 | Sale | 55,810.0 | $1.14 |
| GADICKE ANSBERT | TenPercentOwner | 2025-11-11 | Sale | 55,810.0 | $1.14 |
| MPM ASSET MANAGEMENT LLC | TenPercentOwner | 2025-11-11 | Sale | 55,810.0 | $1.14 |
| MPM BioImpact LLC | TenPercentOwner | 2025-11-11 | Sale | 55,810.0 | $1.14 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2025-11-11 | Sale | 55,810.0 | $1.14 |
| MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | 2025-11-11 | Sale | 55,810.0 | $1.14 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2025-11-11 | Sale | 55,810.0 | $1.14 |
| MPM Oncology Innovations Fund GP LLC | TenPercentOwner | 2025-11-11 | Sale | 55,810.0 | $1.14 |
| EVNIN LUKE | Director | 2025-11-11 | Sale | 35,818.0 | $1.14 |
| MPM BioVentures 2014, L.P. | TenPercentOwner | 2025-11-10 | Sale | 48,570.0 | $1.18 |
| MPM BioVentures 2014 (B), L.P. | TenPercentOwner | 2025-11-10 | Sale | 48,570.0 | $1.18 |
| MPM Asset Management Investors BV2014 LLC | TenPercentOwner | 2025-11-10 | Sale | 48,570.0 | $1.18 |
| MPM BioVentures 2014 LLC | TenPercentOwner | 2025-11-10 | Sale | 48,570.0 | $1.18 |
| MPM BioVentures 2014 GP LLC | TenPercentOwner | 2025-11-10 | Sale | 48,570.0 | $1.18 |
| GADICKE ANSBERT | TenPercentOwner | 2025-11-10 | Sale | 48,570.0 | $1.18 |
| MPM ASSET MANAGEMENT LLC | TenPercentOwner | 2025-11-10 | Sale | 48,570.0 | $1.18 |
| MPM BioImpact LLC | TenPercentOwner | 2025-11-10 | Sale | 48,570.0 | $1.18 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2025-11-10 | Sale | 48,570.0 | $1.18 |
| MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | 2025-11-10 | Sale | 48,570.0 | $1.18 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2025-11-10 | Sale | 48,570.0 | $1.18 |
| MPM Oncology Innovations Fund GP LLC | TenPercentOwner | 2025-11-10 | Sale | 48,570.0 | $1.18 |
| EVNIN LUKE | Director | 2025-11-10 | Sale | 31,172.0 | $1.18 |
| MPM BioVentures 2014, L.P. | TenPercentOwner | 2025-11-07 | Sale | 68,480.0 | $1.11 |
| MPM BioVentures 2014 (B), L.P. | TenPercentOwner | 2025-11-07 | Sale | 68,480.0 | $1.11 |
| MPM Asset Management Investors BV2014 LLC | TenPercentOwner | 2025-11-07 | Sale | 68,480.0 | $1.11 |
| MPM BioVentures 2014 LLC | TenPercentOwner | 2025-11-07 | Sale | 68,480.0 | $1.11 |
| MPM BioVentures 2014 GP LLC | TenPercentOwner | 2025-11-07 | Sale | 68,480.0 | $1.11 |
| GADICKE ANSBERT | TenPercentOwner | 2025-11-07 | Sale | 68,480.0 | $1.11 |
| MPM ASSET MANAGEMENT LLC | TenPercentOwner | 2025-11-07 | Sale | 68,480.0 | $1.11 |
| MPM BioImpact LLC | TenPercentOwner | 2025-11-07 | Sale | 68,480.0 | $1.11 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2025-11-07 | Sale | 68,480.0 | $1.11 |
| MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | 2025-11-07 | Sale | 68,480.0 | $1.11 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2025-11-07 | Sale | 68,480.0 | $1.11 |
| MPM Oncology Innovations Fund GP LLC | TenPercentOwner | 2025-11-07 | Sale | 68,480.0 | $1.11 |
| EVNIN LUKE | Director | 2025-11-07 | Sale | 43,950.0 | $1.11 |
| MPM BioVentures 2014, L.P. | TenPercentOwner | 2025-11-06 | Sale | 54,452.0 | $1.21 |
| MPM BioVentures 2014 (B), L.P. | TenPercentOwner | 2025-11-06 | Sale | 54,452.0 | $1.21 |
| MPM Asset Management Investors BV2014 LLC | TenPercentOwner | 2025-11-06 | Sale | 54,452.0 | $1.21 |
| MPM BioVentures 2014 LLC | TenPercentOwner | 2025-11-06 | Sale | 54,452.0 | $1.21 |
| MPM BioVentures 2014 GP LLC | TenPercentOwner | 2025-11-06 | Sale | 54,452.0 | $1.21 |
| GADICKE ANSBERT | TenPercentOwner | 2025-11-06 | Sale | 54,452.0 | $1.21 |
| MPM ASSET MANAGEMENT LLC | TenPercentOwner | 2025-11-06 | Sale | 54,452.0 | $1.21 |
| MPM BioImpact LLC | TenPercentOwner | 2025-11-06 | Sale | 54,452.0 | $1.21 |
| UBS Oncology Impact Fund L.P. | TenPercentOwner | 2025-11-06 | Sale | 54,452.0 | $1.21 |
| MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | 2025-11-06 | Sale | 54,452.0 | $1.21 |
| Oncology Impact Fund (Cayman) Management L.P. | TenPercentOwner | 2025-11-06 | Sale | 54,452.0 | $1.21 |
| MPM Oncology Innovations Fund GP LLC | TenPercentOwner | 2025-11-06 | Sale | 54,452.0 | $1.21 |
| EVNIN LUKE | Director | 2025-11-06 | Sale | 34,947.0 | $1.21 |
| MPM BioVentures 2014, L.P. | TenPercentOwner | 2025-11-05 | Sale | 47,950.0 | $1.22 |